Feed MANE
MA
Veradermics, Incorporated
MANE · NYSE
$111.48 +3.01% (+$3.26)
1M +2.06%
Valuation
-
N/A P/FCF N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
46 /100
Moderate Beta 1.35x
Profitable years N/A
Rev. volatility N/A
Întreabă StockBot despre MANE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Reid Waldman
Employees
24
Headquarters
New Haven
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report